Abstract
Replication of the human papillomavirus (HPV) double-stranded DNA genome is accomplished by the two viral proteins E1 and E2 in concert with host DNA replication factors. HPV DNA replication is an established model of eukaryotic DNA replication and a potential target for antiviral therapy. Assays to measure the transient replication of HPV DNA in transfected cells have been developed, which rely on a plasmid carrying the viral origin of DNA replication (ori) together with expression vectors for E1 and E2. Replication of the ori-plasmid is typically measured by Southern blotting or PCR analysis of newly replicated DNA (i.e., DpnI digested DNA) several days post-transfection. Although extremely valuable, these assays have been difficult to perform in a high-throughput and quantitative manner. Here, we describe a modified version of the transient DNA replication assay that circumvents these limitations by incorporating a firefly luciferase expression cassette in cis of the ori. Replication of this ori-plasmid by E1 and E2 results in increased levels of firefly luciferase activity that can be accurately quantified and normalized to those of Renilla luciferase expressed from a control plasmid, thus obviating the need for DNA extraction, digestion, and analysis. We provide a detailed protocol for performing the HPV type 31 DNA replication assay in a 96-well plate format suitable for small-molecule screening and EC50 determinations. The quantitative and high-throughput nature of the assay should greatly facilitate the study of HPV DNA replication and the identification of inhibitors thereof.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hebner CM, Laimins LA (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16:83–97
Clertant P, Seif I (1984) A common function for polyoma virus large-T and papillomavirus E1 proteins? Nature 311:276–279
Mansky KC, Batiza A, Lambert PF (1997) Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions. J Virol 71:7600–7608
Li D, Zhao R, Lilyestrom W, Gai D, Zhang R, DeCaprio JA, Fanning E, Jochimiak A, Szakonyi G, Chen XS (2003) Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen. Nature 423:512–518
Titolo S, Pelletier A, Pulichino AM, Brault K, Wardrop E, White PW, Cordingley MG, Archambault J (2000) Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin. J Virol 74:7349–7361
White PW, Pelletier A, Brault K, Titolo S, Welchner E, Thauvette L, Fazekas M, Cordingley MG, Archambault J (2001) Characterization of recombinant HPV6 and 11 E1 helicases: effect of ATP on the interaction of E1 with E2 and mapping of a minimal helicase domain. J Biol Chem 276:22426–22438
Amin AA, Titolo S, Pelletier A, Fink D, Cordingley MG, Archambault J (2000) Identification of domains of the HPV11 E1 protein required for DNA replication in vitro. Virology 272:137–150
Conger KL, Liu JS, Kuo SR, Chow LT, Wang TS (1999) Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase. J Biol Chem 274:2696–2705
Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA, Chow LT (1999) Human papillomavirus DNA replication compartments in a transient DNA replication system. J Virol 73:1001–1009
Clower RV, Hu Y, Melendy T (2006) Papillomavirus E2 protein interacts with and stimulates human topoisomerase I. Virology 348:13–18
Clower RV, Fisk JC, Melendy T (2006) Papillomavirus E1 protein binds to and stimulates human topoisomerase I. J Virol 80:1584–1587
Del Vecchio AM, Romanczuk H, Howley PM, Baker CC (1992) Transient replication of human papillomavirus DNAs. J Virol 66:5949–5958
Taylor ER, Morgan IM (2003) A novel technique with enhanced detection and quantitation of HPV-16 E1- and E2-mediated DNA replication. Virology 315:103–109
Fradet-Turcotte A, Morin G, Lehoux M, Bullock PA, Archambault J (2010) Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology 399:65–76
Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, Archambault J (2011) Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol 85:8996–9012
Morin G, Fradet-Turcotte A, Di Lello P, Bergeron-Labrecque F, Omichinski JG, Archambault J (2011) A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J Virol 85:5287–5300
Lehoux M, Fradet-Turcotte A, Lussier-Price M, Omichinski JG, Archambault J (2012) Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide. J Virol 86:3486–3500
Acknowledgements
Development of this assay was supported by grants from the Canadian Institutes of Health Research (CIHR).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gagnon, D., Fradet-Turcotte, A., Archambault, J. (2015). A Quantitative and High-Throughput Assay of Human Papillomavirus DNA Replication. In: Keppler, D., Lin, A. (eds) Cervical Cancer. Methods in Molecular Biology, vol 1249. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2013-6_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2013-6_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2012-9
Online ISBN: 978-1-4939-2013-6
eBook Packages: Springer Protocols